| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other non-operating loss | -8,450 | -5,929 | -9,674 | -2,260 |
| Loss before provision for income taxes | -16,504 | -17,140 | -19,585 | -16,113 |
| Income tax benefit | 0 | -131 | - | - |
| Net loss | -16,504 | -17,009 | -19,585 | -16,113 |
| Basic (in dollars per share) | -0.14 | -0.15 | -0.21 | -0.18 |
| Basic (in shares) | 97,474,797 | 93,203,665 | 77,098,825 | 75,524,823 |
| Diluted (in dollars per share) | -0.14 | -0.15 | -0.21 | -0.18 |
| Diluted (in shares) | 97,474,797 | 93,203,665 | 77,098,825 | 75,524,823 |
Oncology Institute, Inc. (DFPH)
Oncology Institute, Inc. (DFPH)